1,112 Patient Study Demonstrates Clinical Utility and Care Benefits of KidneyIntelX™ Risk Stratification in Stage 1 to 3 Diabetic Kidney Disease Patients Published 2 years ago on June 10, 2022 By Related Topics: Trending Artificial Intelligence3 days ago CleverTap launches Clever.AI, the AI-Driven Edge for Customer Engagement & Retention Artificial Intelligence7 days ago SUNRATE partners with YeePay to empower Chinese companies to navigate global expansion Uncategorized4 days ago Improving the Developer Journey in Crafting Artificial Intelligence Applications Uncategorized7 days ago Intel unveils AI-Platform Innovation for Paris 2024 Artificial Intelligence5 days ago Appdome Unveils World’s First Agentless Mobile EDR & MTD Uncategorized4 days ago Unveiling the Complex Psychological Implications of Artificial Intelligence